Leflunomide Related Compounds & Impurities

Leflunomide is a DHODH inhibitor prodrug that suppresses pyrimidine synthesis in activated lymphocytes, used for rheumatoid and psoriatic arthritis.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Leflunomide reference standards, pharmacopeial and non-pharmacopeial Leflunomide impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Leflunomide-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Leflunomide
Leflunomide Impurity
Leflunomide Related Compound B
Leflunomide EP Impurity C
Leflunomide EP Impurity A
Leflunomide EP Impurity E
Leflunomide EP Impurity H
Leflunomide EP Impurity B
Ethyl 3-methylisoxazole-4-carboxylate
Leflunomide EP Impurity D
Leflunomide EP Impurity F
Leflunomide EP Impurity G
Teriflunomide Impurity 2
3-Methylisoxazole-4-carboxylic Acid
Leflunomide Impurity 3
Teriflunomide Impurity 3
Teriflunomide Impurity 16
Teriflunomide Impurity 7
2-Chlorobenzotrifluoride
2-Aminobenzotrifluoride
2-cyano-2hydroxy-N-(4-(trifluromethyl)phenyl)acetamide
Teriflunomide Impurity 8
4-Nitrobenzylfluoride
Leflunomide EP Impurity F
2-Hydroxy-N-(4-trifluoromethyl)phenyl)propanamide
3-hydroxy-N-(4-(trifluoromethyl)phenyl)propanamide
Teriflunamide Impurity 4
3-Trifluoro Isomer
2-Cyano-3-hydroxy-but-2-enoic acid (3-trifluoromethylphenyl)amide
Teriflunomide-Ortho-isomer
Teriflunamide Impurity 20
Teriflunamide Impurity 21
(E)-Teriflunomide
Teriflunomide Impurity F
Teriflunomide impurity G
4-amino-N,N'-bis(4-(trifluoromethyl)phenyl)benzimidamide(E/Z mixture)
Teriflunomide Ortho Isomer
2 cyano-3-hydroxy-N-[3-(trifluoromethyl)phenyl]but-2-enamide
Nitroso-Teriflunomide
Teriflunomide Impurity 28
Leflunomide Metabolite Ethyl Analog
Leflunomide EP Impurity A Hydrochloride
Teriflunomide Meta Impurity
Malonamic Acid
Teriflunomide Ortho Impurity
Teriflunomide Lactose Adduct 1
Teriflunomide Lactose Adduct 2
Leflunomide Form 1
Leflunomide Impurity 4
Teriflunomide Impurity A
Leflunomide Impurity 5
Teriflunomide Impurity 17
Teriflunomide Impurity 1
Teriflunomide Impurity 4
N-Nitroso leflunomide impurity 1
Leflunomide Impurity 6
Leflunomide Impurity 2

Isotope Labelled Compounds

Teriflunomide-d4
Leflunomide-D4